Bridgewater Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$998K Sell
15,595
-56,216
-78% -$3.69M ﹤0.01% 838
2026
Q1
$5.11M Buy
71,811
+57,329
+396% +$4.52M 0.02% 416
2025
Q4
$1.19M Sell
14,482
-696
-5% -$54.2K ﹤0.01% 856
2025
Q3
$1.14M Buy
15,178
+112
+0.7% +$8.35K ﹤0.01% 834
2025
Q2
$1.12M Sell
15,066
-111,996
-88% -$7.8M ﹤0.01% 465
2025
Q1
$10.3M Buy
127,062
+95,043
+297% +$8.17M 0.05% 258
2024
Q4
$2.5M Sell
32,019
-24,558
-43% -$2.09M 0.01% 422
2024
Q3
$5.31M Sell
56,577
-106,095
-65% -$8.91M 0.03% 364
2024
Q2
$12.7M Buy
162,672
+148,277
+1,030% +$12.1M 0.07% 216
2024
Q1
$1.31M Buy
+14,395
New +$1.2M 0.01% 545

Other funds holding GEHC

Bridgewater Associates's GEHC Position: Q2 2026 in Review

Bridgewater Associates reduced its GE HealthCare (GEHC) stake by 78% in Q2 2026, selling an estimated $3.69M and leaving 15,595 shares worth $998K. The position accounts for ﹤0.01% of the portfolio, ranked #838.

Bridgewater Associates first reported a position in GEHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.7M in Q2 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bridgewater Associates held 15,595 shares of GE HealthCare worth $998K as of Q2 2026.
  • Bridgewater Associates sold 56,216 GE HealthCare shares in Q2 2026, an estimated $3.69M.
  • GE HealthCare made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #838 holding.
  • Bridgewater Associates first reported a position in GE HealthCare in Q1 2024 and has held it in 10 quarters since.
  • Bridgewater Associates's GE HealthCare position peaked at $12.7M in Q2 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.